Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Dec. 31, 2025
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Mr. Josh Ofman [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On December 2, 2025, Dr. Joshua Ofman, President of the Company, modified a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) (as modified, the “2026 Ofman Trading Arrangement”). The 2026 Ofman Trading Arrangement modifies the 2025 Ofman Trading Arrangement, as defined in our Quarterly Report on Form 10-Q for the three months ended March 31, 2025, and provides for the sale of up to 86,452 shares of common stock, subject to price limitations, until February 20, 2027.
|
| Name | Dr. Joshua Ofman |
| Title | President |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | December 2, 2025 |
| Expiration Date | February 20, 2027 |
| Arrangement Duration | 445 days |
| Aggregate Available | 86,452 |
| Mr. Aaron Freidin [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On December 11, 2025, Mr. Aaron Freidin, Chief Financial Officer of the Company, modified a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) (as modified, the “2026 Freidin Trading Arrangement”). The 2026 Freidin Trading Arrangement modifies the 2025 Freidin Trading Arrangement, as defined in our Quarterly Report on Form 10-Q for the three months ended March 31, 2025, and provides for the sale of up to 21,000 shares of common stock, subject to price limitations, until March 19, 2027.
|
| Name | Mr. Aaron Freidin |
| Title | Chief Financial Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | December 11, 2025 |
| Expiration Date | March 19, 2027 |
| Arrangement Duration | 463 days |
| Aggregate Available | 21,000 |